BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nibourg GA, Chamuleau RA, van der Hoeven TV, Maas MA, Ruiter AF, Lamers WH, Oude Elferink RP, van Gulik TM, Hoekstra R. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure. PLoS One 2012;7:e38778. [PMID: 22719943 DOI: 10.1371/journal.pone.0038778] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Furth ME, Atala A. Tissue Engineering. Principles of Tissue Engineering. Elsevier; 2014. pp. 83-123. [DOI: 10.1016/b978-0-12-398358-9.00006-9] [Cited by in Crossref: 11] [Article Influence: 1.4] [Reference Citation Analysis]
2 Wagner A, Röhrs V, Materne EM, Hiller T, Kedzierski R, Fechner H, Lauster R, Kurreck J. Use of a three-dimensional humanized liver model for the study of viral gene vectors. J Biotechnol 2015;212:134-43. [PMID: 26356676 DOI: 10.1016/j.jbiotec.2015.08.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
3 van der Mark VA, Rudi de Waart D, Shevchenko V, Elferink RP, Chamuleau RA, Hoekstra R. Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells. Drug Metab Dispos 2017;45:56-67. [PMID: 27780834 DOI: 10.1124/dmd.116.072603] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
4 Pasqua M, Pereira U, Messina A, de Lartigue C, Vigneron P, Dubart-Kupperschmitt A, Legallais C. HepaRG Self-Assembled Spheroids in Alginate Beads Meet the Clinical Needs for Bioartificial Liver. Tissue Eng Part A 2020;26:613-22. [PMID: 31914890 DOI: 10.1089/ten.TEA.2019.0262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pluta KD, Ciezkowska M, Wisniewska M, Wencel A, Pijanowska DG. Cell-based clinical and experimental methods for assisting the function of impaired livers – Present and future of liver support systems. Biocybernetics and Biomedical Engineering 2021;41:1322-46. [DOI: 10.1016/j.bbe.2021.06.005] [Reference Citation Analysis]
6 Wigger L, Casals-Casas C, Baruchet M, Trang KB, Pradervand S, Naldi A, Desvergne B. System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells. PLoS One 2019;14:e0220894. [PMID: 31437187 DOI: 10.1371/journal.pone.0220894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xu S, Zhao M, Wang Q, Xu Z, Pan B, Xue Y, Dai Z, Wang S, Xue Z, Wang F, Xu C. Effectiveness of Probiotics and Prebiotics Against Acute Liver Injury: A Meta-Analysis. Front Med (Lausanne) 2021;8:739337. [PMID: 34621765 DOI: 10.3389/fmed.2021.739337] [Reference Citation Analysis]
8 Nibourg GAA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TBM, van Gulik TM, Chamuleau RAFM. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-Bioartificial Liver. Liver Int 2013;33:516-24. [DOI: 10.1111/liv.12090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
9 Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D. Bioengineering Organs for Blood Detoxification. Adv Healthc Mater 2018;7:e1800430. [PMID: 30230709 DOI: 10.1002/adhm.201800430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
10 Nibourg GA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Chamuleau RA. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor. Int J Biochem Cell Biol 2013;45:1860-8. [PMID: 23770120 DOI: 10.1016/j.biocel.2013.05.038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
11 Nicolas C, Wang Y, Luebke-Wheeler J, Nyberg SL. Stem Cell Therapies for Treatment of Liver Disease. Biomedicines 2016;4:E2. [PMID: 28536370 DOI: 10.3390/biomedicines4010002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
12 Herzog N, Hansen M, Miethbauer S, Schmidtke KU, Anderer U, Lupp A, Sperling S, Seehofer D, Damm G, Scheibner K, Küpper JH. Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures. Cell Biol Int 2016;40:341-53. [PMID: 26715207 DOI: 10.1002/cbin.10574] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
13 Fang SY, Hu CQ, Liu MN, Tao L, Wang Y, Gong MJ, He Y, He TC, Bi Y. Reversibly immortalized hepatic progenitor cell line containing double suicide genes. Int J Mol Med 2018;42:1977-86. [PMID: 30085335 DOI: 10.3892/ijmm.2018.3803] [Reference Citation Analysis]
14 Moedas M, Adam A, Farelo M, Ijlst L, Chamuleau R, Hoekstra R, Wanders R, Silva M. Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS. Analytical Biochemistry 2017;535:47-55. [DOI: 10.1016/j.ab.2017.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
15 Figaro S, Pereira U, Rada H, Semenzato N, Pouchoulin D, Paullier P, Dufresne M, Legallais C. Optimizing the fluidized bed bioreactor as an external bioartificial liver. Int J Artif Organs 2017;40:196-203. [PMID: 28362045 DOI: 10.5301/ijao.5000567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
16 Sen S, Sanyal S, Srivastava DK, Dasgupta D, Roy S, Das C. Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex. J Biol Chem 2017;292:20362-78. [PMID: 29042441 DOI: 10.1074/jbc.M117.786863] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
17 van Wenum M, Adam AA, Hakvoort TB, Hendriks EJ, Shevchenko V, van Gulik TM, Chamuleau RA, Hoekstra R. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines. Int J Biol Sci 2016;12:964-78. [PMID: 27489500 DOI: 10.7150/ijbs.15165] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
18 Adam AAA, van der Mark VA, Ruiter JPN, Wanders RJA, Oude Elferink RPJ, Chamuleau RAFM, Hoekstra R. Overexpression of carbamoyl-phosphate synthase 1 significantly improves ureagenesis of human liver HepaRG cells only when cultured under shaking conditions. Mitochondrion 2019;47:298-308. [PMID: 30802674 DOI: 10.1016/j.mito.2019.02.005] [Reference Citation Analysis]
19 Selden C, Spearman CW, Kahn D, Miller M, Figaji A, Erro E, Bundy J, Massie I, Chalmers SA, Arendse H, Gautier A, Sharratt P, Fuller B, Hodgson H. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting. PLoS One. 2013;8:e82312. [PMID: 24367515 DOI: 10.1371/journal.pone.0082312] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
20 Nelson LJ, Treskes P, Howie AF, Walker SW, Hayes PC, Plevris JN. Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro. Sci Rep 2013;3:2735. [PMID: 24061220 DOI: 10.1038/srep02735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
21 van Wenum M, Treskes P, Tang CY, Coppens EJ, Jansen K, Hendriks EJ, Camus S, van Gulik TM, Chamuleau RAFM, Hoekstra R. Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport. Biofabrication 2017;9:035001. [PMID: 28664876 DOI: 10.1088/1758-5090/aa7657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
22 Adam AAA, van der Mark VA, Donkers JM, Wildenberg ME, Oude Elferink RPJ, Chamuleau RAFM, Hoekstra R. A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines. PLoS One 2018;13:e0193664. [PMID: 29672606 DOI: 10.1371/journal.pone.0193664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
23 Adam AAA, Jongejan A, Moerland PD, van der Mark VA, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. Genome-wide expression profiling reveals increased stability and mitochondrial energy metabolism of the human liver cell line HepaRG-CAR. Cytotechnology 2020;72:377-95. [PMID: 32130581 DOI: 10.1007/s10616-020-00384-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Mayati A, Moreau A, Le Vée M, Bruyère A, Jouan E, Denizot C, Parmentier Y, Fardel O. Functional polarization of human hepatoma HepaRG cells in response to forskolin. Sci Rep 2018;8:16115. [PMID: 30382126 DOI: 10.1038/s41598-018-34421-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Adam AAA, van Wenum M, van der Mark VA, Jongejan A, Moerland PD, Houtkooper RH, Wanders RJA, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration. Mitochondrion 2018;39:30-42. [PMID: 28844938 DOI: 10.1016/j.mito.2017.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
26 Ebrahimkhani MR, Neiman JA, Raredon MS, Hughes DJ, Griffith LG. Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev. 2014;69-70:132-157. [PMID: 24607703 DOI: 10.1016/j.addr.2014.02.011] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 11.8] [Reference Citation Analysis]
27 Ramaiahgari SC, Waidyanatha S, Dixon D, DeVito MJ, Paules RS, Ferguson SS. From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening. Toxicol Sci 2017;159:124-36. [PMID: 28633424 DOI: 10.1093/toxsci/kfx122] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
28 Corrado B, Gregorio V, Imparato G, Attanasio C, Urciuolo F, Netti PA. A three‐dimensional microfluidized liver system to assess hepatic drug metabolism and hepatotoxicity. Biotechnology and Bioengineering 2019;116:1152-63. [DOI: 10.1002/bit.26902] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
29 Lee KCL, Stadlbauer V, Jalan R. Extracorporeal liver support devices for listed patients: Extracorporeal Liver Support Devices. Liver Transpl 2016;22:839-48. [DOI: 10.1002/lt.24396] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
30 Hoekstra R, Nibourg GA, van der Hoeven TV, Plomer G, Seppen J, Ackermans MT, Camus S, Kulik W, van Gulik TM, Elferink RP. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide. Drug Metab Dispos. 2013;41:562-567. [PMID: 23238784 DOI: 10.1124/dmd.112.049098] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
31 Nibourg GA, Boer JD, van der Hoeven TV, Ackermans MT, van Gulik TM, Chamuleau RA, Hoekstra R. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver. Biotechnol Bioeng 2012;109:3182-8. [PMID: 22729831 DOI: 10.1002/bit.24586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
32 Mueller D, Krämer L, Hoffmann E, Klein S, Noor F. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicology in Vitro 2014;28:104-12. [DOI: 10.1016/j.tiv.2013.06.024] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 12.1] [Reference Citation Analysis]
33 Wlodzimirow K, Abu-hanna A, Schultz M, Maas M, Bos L, Sterk P, Knobel H, Soers R, Chamuleau RA. Exhaled breath analysis with electronic nose technology for detection of acute liver failure in rats. Biosensors and Bioelectronics 2014;53:129-34. [DOI: 10.1016/j.bios.2013.09.047] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
34 Koblihová E, Mrázová I, Vernerová Z, Ryska M. Acute Liver Failure Induced by Thioacetamide: Selection of Optimal Dosage in Wistar and Lewis Rats. Physiol Res. [DOI: 10.33549/physiolres.932690] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
35 Baquerizo A, Bañares R, Saliba F. Current Clinical Status of the Extracorporeal Liver Support Devices. Transplantation of the Liver. Elsevier; 2015. pp. 1463-87. [DOI: 10.1016/b978-1-4557-0268-8.00107-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Rebelo SP, Costa R, Estrada M, Shevchenko V, Brito C, Alves PM. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism. Arch Toxicol 2015;89:1347-58. [PMID: 25107451 DOI: 10.1007/s00204-014-1320-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]